Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Nat Commun ; 8: 16074, 2017 07 18.
Artigo em Inglês | MEDLINE | ID: mdl-28719575

RESUMO

Notch signalling is a causal determinant of cancer and efforts have been made to develop targeted therapies to inhibit the so-called canonical pathway. Here we describe an unexpected pro-apoptotic role of Notch3 in regulating tumour angiogenesis independently of the Notch canonical pathway. The Notch3 ligand Jagged-1 is upregulated in a fraction of human cancer and our data support the view that Jagged-1, produced by cancer cells, is inhibiting the apoptosis induced by the aberrant Notch3 expression in tumour vasculature. We thus present Notch3 as a dependence receptor inducing endothelial cell death while this pro-apoptotic activity is blocked by Jagged-1. Along this line, using Notch3 mutant mice, we demonstrate that tumour growth and angiogenesis are increased when Notch3 is silenced in the stroma. Consequently, we show that the well-documented anti-tumour effect mediated by γ-secretase inhibition is at least in part dependent on the apoptosis triggered by Notch3 in endothelial cells.


Assuntos
Carcinoma Pulmonar de Células não Pequenas/metabolismo , Células Endoteliais/metabolismo , Neoplasias Pulmonares/metabolismo , Neovascularização Patológica , Receptor Notch3/metabolismo , Secretases da Proteína Precursora do Amiloide/antagonistas & inibidores , Animais , Morte Celular , Células HEK293 , Células Endoteliais da Veia Umbilical Humana , Humanos , Proteína Jagged-1/metabolismo , Camundongos Endogâmicos C57BL
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA